Related Experiment Video
Updated: Jun 21, 2025

Optical Tweezers to Study RNA-Protein Interactions in Translation Regulation
Published on: February 12, 2022
Spatiotemporally Controllable Covalent Bonding of RNA for Multi-Protein Interference
Hao Fang1, Tingting Wang1, Jun Dai2
1State Key Laboratory of Biogeology and Environmental Geology, Faculty of Materials Science and Chemistry, China University of Geosciences, Wuhan, 430074, China.
Abstract:
Many diseases are associated with genetic mutation and expression of mutated proteins, such as cancers. Therapeutic approaches that selectively target the synthesis process of multiple proteins show greater potential compared to single-protein approaches in oncological diseases. However, conventional agents to regulate the synthesis of multiple protein still suffer from poor spatiotemporal selectivity and stability. Here, a new method using a dye-peptide conjugate, PRFK, for multi-protein interference with spatiotemporal selectivity and reliable stability, is reported. By using the peptide sequence that targets tumor cells, PRFK can be efficiently taken up, followed by specific binding to the KDELR (KDEL receptor) protein located in the endoplasmic reticulum (ER). The dye generates 1O2 under light irradiation, enabling photodynamic therapy. This process converts the furan group into a cytidine-reactive intermediate, which covalently binds to mRNA, thereby blocking protein synthesis. Upon treating 4T1 cells, the proteomics data show alterations in apoptosis, ferroptosis, proliferation, migration, invasion, and immune infiltration, suggesting that multi-protein interference leads to the disruption of cellular physiological activities, ultimately achieving tumor treatment. This study presents a multi-protein interference probe with the potential for protein interference within various subcellular organelles in the future.
Insights
Researchers developed PRFK, a novel dye-peptide conjugate that selectively targets and inhibits multiple protein synthesis in cancer cells. This photodynamic therapy approach offers improved spatiotemporal control for potential oncological treatments.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Cancer Research
Background:
- Genetic mutations and aberrant protein expression are hallmarks of diseases like cancer.
- Targeting multiple protein synthesis pathways offers a promising therapeutic strategy for oncological diseases.
- Existing multi-protein synthesis regulators lack precise spatiotemporal control and stability.
Purpose of the Study:
- To develop a novel dye-peptide conjugate, PRFK, for targeted multi-protein interference with spatiotemporal selectivity and stability.
- To investigate the mechanism of PRFK-mediated protein synthesis inhibition.
- To evaluate the therapeutic potential of PRFK in a cancer cell model.
Main Methods:
- Design and synthesis of the PRFK dye-peptide conjugate.
- Utilizing a tumor-targeting peptide for cellular uptake and KDEL receptor (KDELR) binding in the endoplasmic reticulum (ER).
- Employing light-activated photodynamic therapy to generate singlet oxygen (1O2) and create a cytidine-reactive intermediate.
- Covalent binding of the intermediate to mRNA to inhibit protein synthesis.
- Proteomic analysis of treated 4T1 cells to assess cellular pathway alterations.
Main Results:
- PRFK demonstrated efficient uptake and specific binding to KDELR in tumor cells.
- Light irradiation triggered 1O2 generation and subsequent mRNA targeting, blocking protein synthesis.
- Proteomics data revealed significant alterations in apoptosis, ferroptosis, proliferation, migration, invasion, and immune infiltration pathways in 4T1 cells.
- PRFK effectively disrupted cellular physiological activities, leading to tumor treatment outcomes.
Conclusions:
- PRFK serves as a potent multi-protein interference probe with enhanced spatiotemporal selectivity and stability.
- The study validates multi-protein interference as a viable strategy for cancer therapy.
- PRFK holds potential for targeting protein synthesis in various subcellular organelles for future therapeutic applications.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Structure
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...
Nucleic Acid Structure
DNA Structure
DNA...
RNA Stability

